What is William Blair's Forecast for HURN FY2025 Earnings?

Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) - Analysts at William Blair raised their FY2025 earnings estimates for shares of Huron Consulting Group in a research report issued to clients and investors on Wednesday, April 30th. William Blair analyst A. Nicholas now forecasts that the business services provider will post earnings of $7.50 per share for the year, up from their previous estimate of $7.09. William Blair currently has a "Outperform" rating on the stock. The consensus estimate for Huron Consulting Group's current full-year earnings is $6.10 per share. William Blair also issued estimates for Huron Consulting Group's Q1 2026 earnings at $1.32 EPS, Q2 2026 earnings at $2.11 EPS, Q3 2026 earnings at $2.40 EPS, Q4 2026 earnings at $2.33 EPS and FY2026 earnings at $8.15 EPS.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The business services provider reported $1.68 EPS for the quarter, beating analysts' consensus estimates of $1.16 by $0.52. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The firm had revenue of $404.14 million for the quarter, compared to analyst estimates of $389.27 million. During the same period last year, the company earned $1.23 EPS. The business's quarterly revenue was up 11.2% compared to the same quarter last year.

A number of other equities research analysts have also commented on the company. Wedbush raised their price target on Huron Consulting Group from $150.00 to $165.00 and gave the stock an "outperform" rating in a research report on Wednesday, March 26th. Truist Financial raised their price target on shares of Huron Consulting Group from $165.00 to $180.00 and gave the stock a "buy" rating in a research note on Tuesday, March 4th. StockNews.com lowered shares of Huron Consulting Group from a "buy" rating to a "hold" rating in a research report on Friday. Benchmark restated a "buy" rating and issued a $165.00 price target on shares of Huron Consulting Group in a research note on Wednesday, March 26th. Finally, Barrington Research lifted their price objective on shares of Huron Consulting Group from $167.00 to $173.00 and gave the stock an "outperform" rating in a research report on Monday. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $170.75.

Huron Consulting Group Trading Down 0.1 %

Shares of Huron Consulting Group stock traded down $0.17 during trading on Thursday, reaching $148.14. 54,286 shares of the company were exchanged, compared to its average volume of 147,919. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82. The firm has a market capitalization of $2.56 billion, a price-to-earnings ratio of 32.19 and a beta of 0.23. The business has a 50-day moving average price of $143.10 and a 200-day moving average price of $130.24. Huron Consulting Group has a twelve month low of $84.87 and a twelve month high of $153.85.

Insider Activity

In related news, CEO C. Mark Hussey sold 27,672 shares of the business's stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $145.91, for a total transaction of $4,037,621.52. Following the sale, the chief executive officer now owns 81,118 shares in the company, valued at $11,835,927.38. The trade was a 25.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director James H. Roth sold 2,000 shares of Huron Consulting Group stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $126.03, for a total value of $252,060.00. Following the sale, the director now directly owns 48,534 shares in the company, valued at $6,116,740.02. The trade was a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 78,239 shares of company stock worth $11,420,861. Insiders own 2.15% of the company's stock.

Hedge Funds Weigh In On Huron Consulting Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in HURN. Opal Wealth Advisors LLC acquired a new position in Huron Consulting Group in the first quarter valued at $35,000. Heck Capital Advisors LLC acquired a new position in shares of Huron Consulting Group during the 4th quarter valued at $33,000. CWM LLC grew its holdings in Huron Consulting Group by 55.9% in the first quarter. CWM LLC now owns 407 shares of the business services provider's stock worth $58,000 after purchasing an additional 146 shares during the period. Tower Research Capital LLC TRC increased its stake in Huron Consulting Group by 27.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 569 shares of the business services provider's stock valued at $71,000 after purchasing an additional 122 shares in the last quarter. Finally, USA Financial Formulas bought a new stake in Huron Consulting Group in the first quarter valued at $114,000. 93.90% of the stock is currently owned by institutional investors and hedge funds.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.